KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Short-term Investments (2016 - 2025)

Novavax has reported Short-term Investments over the past 14 years, most recently at $494.4 million for Q4 2025.

  • Quarterly results put Short-term Investments at $494.4 million for Q4 2025, up 25.85% from a year ago — trailing twelve months through Dec 2025 was $494.4 million (up 25.85% YoY), and the annual figure for FY2025 was $494.4 million, up 25.85%.
  • Short-term Investments for Q4 2025 was $494.4 million at Novavax, roughly flat from $494.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for NVAX hit a ceiling of $494.9 million in Q3 2025 and a floor of $2.2 million in Q1 2021.
  • Median Short-term Investments over the past 3 years was $381.2 million (2024), compared with a mean of $364.6 million.
  • Biggest five-year swings in Short-term Investments: crashed 96.09% in 2021 and later soared 47.34% in 2025.
  • Novavax's Short-term Investments stood at $2.2 million in 2021, then surged by 17361.69% to $392.9 million in 2024, then increased by 25.85% to $494.4 million in 2025.
  • The last three reported values for Short-term Investments were $494.4 million (Q4 2025), $494.9 million (Q3 2025), and $358.6 million (Q2 2025) per Business Quant data.